Other
Equity method investments (Note 11)
Pfizer Equity method investments (Note 11) increased by 0.9% to $237.00M in Q1 2026 compared to the prior quarter.
Analysis
StatementBalance Sheet Statement
SectionOther
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ1 2026
Last reportedQ1 2026
How to read this metric
Growth indicates strategic expansion into partnerships, while a decline may signal divestment or poor performance of the investee.
Detailed definition
This represents the company's investment in entities where it exercises significant influence but does not have full con...
Peer comparison
Common in the mining sector for joint ventures; peers often use this to share risk in large-scale projects.
Metric ID:
other_equity_method_investmentsHistorical Data
2 periods
| Q4 '25 | Q1 '26 | |
|---|---|---|
| Value | $235.00M | $237.00M |
| QoQ Change | — | +0.9% |
Range$235.00M – $237.00M
Equity method investments (Note 11) at Other Companies
Frequently Asked Questions
- What is Pfizer's equity method investments (note 11)?
- Pfizer (PFE) reported equity method investments (note 11) of $237.00M in Q1 2026.
- What does equity method investments (note 11) mean?
- Investments in companies where the firm has significant influence but not control.